Selinexor in relapsed/refractory multiple myeloma

Richter, J; Madduri, D; Richard, S; Chari, A

Richter, J (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Ringgold Stand Inst Hematol Oncol, 1 Gustave L Levy Pl, New York, NY 10029 USA.

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020; 11 ():

Abstract

Multiple myeloma (MM) represents an incurable hematologic malignancy. Despite significant advances over the past decade, with the advent of multiple n......

Full Text Link